Basic Information
| LncRNA/CircRNA Name | OSTN-AS1 |
| Synonyms | NA |
| Region | GRCh38_3:191213291-191234605 |
| Ensemble | ENSG00000233308 |
| Refseq | NR_133663 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | qPCR |
| Sample | prostate cancer cell lines (WPMY1, PC3 and DU145) |
| Expression Pattern | up-regulated |
| Function Description | The results showed that LINC00308, LINC00355, and OSTN-AS1 are overexpressed in the prostate cancer cell line compared to the normal myofibroblast stromal cell line. LINC00308, LINC00355, and OSTN-AS1) were significantly associated with overall survival (log-rank P<0.05). |
| Pubmed ID | 29923546 |
| Year | 2018 |
| Title | Identification of Potential Prostate Cancer-Related Pseudogenes Based on Competitive Endogenous RNA Network Hypothesis |
External Links
| Links for OSTN-AS1 | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |